Efficacy and Safety of Microwave Ablation Assisted by Ultrasound Fusion Imaging for Primary and Secondary Liver Cancers with a Diameter of 3–7 Cm

References

• European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
   PubMed Web of Science ®Google Scholar
• Kutlu OC, Chan JA, Aloia TA, et al. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer. 2017;123(10):1817–1827. doi:10.1002/cncr.30531
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57(4):794–802. doi:10.1016/j.jhep.2012.05.007
   PubMed Web of Science ®Google Scholar
• Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29(1):193–200. doi:10.1111/jgh.12441
   PubMed Web of Science ®Google Scholar
• Lin CC, Cheng YT, Chen MW, Lin SM. The effectiveness of multiple electrode radiofrequency ablation in patients with hepatocellular carcinoma with lesions more than 3 cm in size and Barcelona clinic liver cancer stage A to B2. Liver Cancer. 2016;5(1):8–20. doi:10.1159/000367755
   PubMed Web of Science ®Google Scholar
• Sun AX, Cheng ZL, Wu PP, et al. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation. World J Gastroenterol. 2015;21(10):2997–3004. doi:10.3748/wjg.v21.i10.2997
   PubMed Web of Science ®Google Scholar
• Kim JH, Won HJ, Shin YM, et al. Medium-sized (3.1–5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol. 2011;18(6):1624–1629. doi:10.1245/s10434-011-1673-8
   PubMed Web of Science ®Google Scholar
• Yin XY, Xie XY, Lu MD, et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer. 2009;115(9):1914–1923. doi:10.1002/cncr.24196
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology. 2009;251(3):933–940. doi:10.1148/radiol.2513081740
   PubMed Web of Science ®Google Scholar
• Li K, Su ZZ, Xu EJ, Ju JX, Meng XC, Zheng RQ. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma. BMC Cancer. 2016;16:277. doi:10.1186/s12885-016-2306-1
   PubMed Web of Science ®Google Scholar
• Ye QW, Pang SJ, Yang N, et al. Safety and efficacy of radiofrequency ablation for solitary hepatocellular carcinoma (3–5 cm): a propensity score matching cohort study. J Gastrointest Surg. 2019;23(8):1549–1558. doi:10.1007/s11605-019-04229-6
   PubMed Web of Science ®Google Scholar
• Chong HH, Yang L, Sheng RF, et al. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm. Eur Radiol. 2021;31(7):4824–4838. doi:10.1007/s00330-020-07601-2
   PubMed Web of Science ®Google Scholar
• Kariyama K, Nouso K, Wakuta A, et al. Treatment of intermediate-stage hepatocellular carcinoma in japan: position of curative therapies. Liver Cancer. 2020;9(1):41–49. doi:10.1159/000502479
   PubMed Web of Science ®Google Scholar
• N’Kontchou G, Nault JC, Sutter O, et al. Multibipolar radiofrequency ablation for the treatment of mass-forming and infiltrative hepatocellular carcinomas > 5 cm: long-term results. Liver Cancer. 2019;8(3):172–185. doi:10.1159/000489319
   PubMed Web of Science ®Google Scholar
• Chong CCN, Lee KF, Cheung SYS, et al. Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial). HPB. 2020;22(8):1121–1127. doi:10.1016/j.hpb.2020.01.008
   PubMed Web of Science ®Google Scholar
• Francica G, Altiero M, Laccetti E, et al. Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system. Br J Radiol. 2019;92(1093):20180625. doi:10.1259/bjr.20180625
   PubMed Web of Science ®Google Scholar
• Huang G, Lin M, Xie X, et al. Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma. Eur Radiol. 2014;24(7):1565–1571. doi:10.1007/s00330-014-3151-8
   PubMed Web of Science ®Google Scholar
• An C, Li X, Zhang M, et al. 3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application. BMC Cancer. 2020;20(1):44. doi:10.1186/s12885-020-6519-y
   PubMed Web of Science ®Google Scholar
• Yuan P, Zhang Z, Kuai J. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma. J buon. 2019;24(1):163–170.
   PubMed Web of Science ®Google Scholar
• Liu C, Li T, He JT, Shao H. TACE combined with microwave ablation therapy vs. TACE alone for treatment of early- and intermediate-stage hepatocellular carcinomas larger than 5 cm: a meta-analysis. Diagn Interv Radiol. 2020;26(6):575–583. doi:10.5152/dir.2020.19615
   PubMed Web of Science ®Google Scholar
• Young S, Golzarian J. Locoregional therapies in the treatment of 3- to 5-cm hepatocellular carcinoma: critical review of the literature. AJR Am J Roentgenol. 2020;215(1):223–234. doi:10.2214/AJR.19.22098
   PubMed Web of Science ®Google Scholar
• Faiella E, Santucci D, Bernetti C, et al. Combined trans-arterial embolisation and microwave ablation for the treatment of large unresectable hepatic metastases (>3 cm in maximal diameter). Int J Hyperthermia. 2020;37(1):1395–1403. doi:10.1080/02656736.2020.1849823
   PubMed Web of Science ®Google Scholar
• Zhu ZY, Yuan M, Yang PP, et al. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score. World J Surg Oncol. 2022;20(1):192. doi:10.1186/s12957-022-02643-w
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Lee JM, Lee DH, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66(2):347–354. doi:10.1016/j.jhep.2016.09.003
   PubMed Web of Science ®Google Scholar
• Xu EJ, Lv SM, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperthermia. 2018;34(6):870–876. doi:10.1080/02656736.2017.1373306
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--A 10-year update. Radiology. 2014;273(1):241–260. doi:10.1148/radiol.14132958
   PubMed Web of Science ®Google Scholar
• Luo L, He X, Li K, et al. Thermal ablation of medium-sized hepatocellular carcinomas using intraoperative ultrasound fusion imaging: a propensity score-matched analysis. Clin Res Hepatol Gastroenterol. 2021;45(5):101581. doi:10.1016/j.clinre.2020.11.011
   PubMed Web of Science ®Google Scholar
• Long Y, Zeng Q, He X, et al. One-lung ventilation for percutaneous thermal ablation of liver tumors in the hepatic dome. Int J Hyperthermia. 2020;37(1):49–54. doi:10.1080/02656736.2019.1708483
   PubMed Web of Science ®Google Scholar
• Huang Q, Li J, Zeng Q, et al. Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery. BMC Cancer. 2020;20(1):763. doi:10.1186/s12885-020-07261-x
   PubMed Web of Science ®Google Scholar
• Xu E, Long Y, Li K, et al. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperthermia. 2019;35(1):159–167. doi:10.1080/02656736.2018.1487591
   PubMed Web of Science ®Google Scholar
• Gordan JD, Kennedy EB, Abou-Alfa GK, et al. Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline. J Clin Oncol. 2020;38(36):4317–4345. doi:10.1200/JCO.20.02672
   PubMed Web of Science ®Google Scholar
• Czauderna C, Luley K, von Bubnoff N, Marquardt JU. Tailored systemic therapy for colorectal cancer liver metastases. Int J Mol Sci. 2021;22(21). doi:10.3390/ijms222111780
   PubMed Web of Science ®Google Scholar
• Patidar Y, Garg L, Mukund A, Sarin SK. Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm. Indian J Radiol Imaging. 2019;29(1):47–52. doi:10.4103/ijri.IJRI_352_18
   PubMedGoogle Scholar
• Liu W, Xu H, Ying X, et al. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for patients with medium-to-large hepatocellular carcinoma: a retrospective analysis of long-term outcome. Med Sci Monit. 2020;26:e923263. doi:10.12659/MSM.923263
   PubMed Web of Science ®Google Scholar
• Wang YH, Liu JF, Li F, et al. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer. Chin Med J. 2009;122(8):889–894.
   PubMed Web of Science ®Google Scholar
• Ni JY, Sun HL, Chen YT, et al. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World J Gastroenterol. 2014;20(46):17483–17490. doi:10.3748/wjg.v20.i46.17483
   PubMed Web of Science ®Google Scholar